Risk Factors of Deterioration in Quality of Life Scores in Thyroid Cancer Patients After Thyroidectomy

References

• Verburg FA, Mader U, Tanase K, et al. Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab. 2013;98:172–180. doi:10.1210/jc.2012-245823150687
   PubMed Web of Science ®Google Scholar
• Maier TM, Schober O, Gerss J, et al. Differentiated thyroid cancer patients more than 60 years old paradoxically show an increased life expectancy. J Nucl Med. 2015;56:190–195. doi:10.2967/jnumed.114.15028425613533
   PubMed Web of Science ®Google Scholar
• Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol. 2011;3:57–71. doi:10.1177/175883401039534221789156
   PubMedGoogle Scholar
• Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(Suppl 1 ):1–122.
   PubMed Web of Science ®Google Scholar
• Botella-Carretero JI, Galan JM, Caballero C, Sancho J, Escobar-Morreale HF. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer. 2003;10:601–610. doi:10.1677/erc.0.010060114713270
   PubMed Web of Science ®Google Scholar
• Giusti M, Sibilla F, Cappi C, et al. A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma. J Endocrinol Invest. 2005;28:599–608. doi:10.1007/BF0334725816218042
   PubMed Web of Science ®Google Scholar
• Tagay S, Herpertz S, Langkafel M, et al. Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res. 2006;15:695–703. doi:10.1007/s11136-005-3689-716688502
   PubMed Web of Science ®Google Scholar
• Schultz PN, Stava C, Vassilopoulou-Sellin R. Health profiles and quality of life of 518 survivors of thyroid cancer. Head Neck. 2003;25:349–356. doi:10.1002/hed.1021712692870
   PubMed Web of Science ®Google Scholar
• Applewhite MK, James BC, Kaplan SP, et al. Quality of life in thyroid cancer is similar to that of other cancers with worse survival. World J Surg. 2016;40:551–561. doi:10.1007/s00268-015-3300-526546191
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi:10.1093/jnci/85.5.3658433390
   PubMed Web of Science ®Google Scholar
• Fayers P, Bottomley A. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002;38(Suppl 4 ):S125–S133. doi:10.1016/S0959-8049(01)00448-811858978
   PubMed Web of Science ®Google Scholar
• Ratjen I, Schafmayer C, Enderle J, et al. Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: a German cohort study. BMC Cancer. 2018;18:1156. doi:10.1186/s12885-018-5075-130466408
   PubMed Web of Science ®Google Scholar
• Giesinger JM, Kieffer JM, Fayers PM, et al. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol. 2016;69:79–88. doi:10.1016/j.jclinepi.2015.08.00726327487
   PubMed Web of Science ®Google Scholar
• Goswami S, Mongelli M, Peipert BJ, Helenowski I, Yount SE, Sturgeon C. Benchmarking health-related quality of life in thyroid cancer versus other cancers and United States normative data. Surgery. 2018;164:986–992. doi:10.1016/j.surg.2018.06.04230149935
   PubMed Web of Science ®Google Scholar
• Gamper EM, Wintner LM, Rodrigues M, et al. Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme. Eur J Nucl Med Mol Imaging. 2015;42:1179–1188. doi:10.1007/s00259-015-3022-925771905
   PubMed Web of Science ®Google Scholar
• Singer S, Lincke T, Gamper E, et al. Quality of life in patients with thyroid cancer compared with the general population. Thyroid. 2012;22:117–124. doi:10.1089/thy.2011.013922191388
   PubMed Web of Science ®Google Scholar
• Hedman C, Djarv T, Strang P, Lundgren CI. Determinants of long-term quality of life in patients with differentiated thyroid carcinoma - a population-based cohort study in Sweden. Acta Oncol. 2016;55:365–369. doi:10.3109/0284186X.2015.110296526541091
   PubMed Web of Science ®Google Scholar
• Saravanan P, Visser TJ, Dayan CM. Psychological well-being correlates with free thyroxine but not free 3,5,3ʹ-triiodothyronine levels in patients on thyroid hormone replacement. J Clin Endocrinol Metab. 2006;91:3389–3393. doi:10.1210/jc.2006-041416804044
   PubMed Web of Science ®Google Scholar
• Wekking EM, Appelhof BC, Fliers E, et al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol. 2005;153:747–753. doi:10.1530/eje.1.0202516322379
   PubMed Web of Science ®Google Scholar
• Husson O, Nieuwlaat WA, Oranje WA, Haak HR, van de Poll-franse LV, Mols F. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid. 2013;23:1247–1255. doi:10.1089/thy.2013.001523578315
   PubMed Web of Science ®Google Scholar
• Bower JE. Prevalence and causes of fatigue after cancer treatment: the next generation of research. J Clin Oncol. 2005;23:8280–8282. doi:10.1200/JCO.2005.08.00816219929
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Del Rey FE, Obregon MJ, de Escobar GM. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology. 1996;137:2490–2502. doi:10.1210/endo.137.6.86412038641203
   PubMed Web of Science ®Google Scholar
• Ladenson PW. Psychological wellbeing in patients. Clin Endocrinol (Oxf). 2002;57:575–576. doi:10.1046/j.1365-2265.2002.01682.x12390329
   PubMed Web of Science ®Google Scholar
• Weetman AP. Whose thyroid hormone replacement is it anyway? Clin Endocrinol (Oxf). 2006;64:231–233. doi:10.1111/cen.2006.64.issue-316487429
   PubMed Web of Science ®Google Scholar
• Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM. Quality of life and cosmetic result of single-port access endoscopic thyroidectomy via axillary approach in patients with papillary thyroid carcinoma. Onco Targets Ther. 2016;9:4053–4059. doi:10.2147/OTT.S9998027445496
   PubMed Web of Science ®Google Scholar
• Husson O, Zebrack BJ, Block R, et al. Health-related quality of life in adolescent and young adult patients with cancer: a longitudinal study. J Clin Oncol. 2017;35:652–659. doi:10.1200/JCO.2016.69.794628095151
   PubMed Web of Science ®Google Scholar
• Goldfarb M, Casillas J. Health-related quality of life in adolescent and young adult patients with cancer: a longitudinal study. J Cancer Surviv. 2014;8:394–401. doi:10.1007/s11764-014-0345-724570216
   PubMed Web of Science ®Google Scholar
• Haraj NE, Bouri H, El Aziz S, Nani S, Habti N, Chadli A. Evaluation of the quality of life in patients followed for differentiated cancer of the thyroid. Ann Endocrinol (Paris). 2019;80:26–31. doi:10.1016/j.ando.2018.01.00329571888
   PubMed Web of Science ®Google Scholar
• Wang T, Jiang M, Ren Y, et al. Health-related quality of life of community thyroid cancer survivors in Hangzhou, China. Thyroid. 2018;28:1013–1023. doi:10.1089/thy.2017.021329808769
   PubMed Web of Science ®Google Scholar
• Nickel B, Tan T, Cvejic E, et al. Health-related quality of life after diagnosis and treatment of differentiated thyroid cancer and association with type of surgical treatment. JAMA Otolaryngol Head Neck Surg. 2019;145:231–238. doi:10.1001/jamaoto.2018.387030653212
   PubMed Web of Science ®Google Scholar
• Dal Maso L, Panato C, Franceschi S, et al. The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998-2012. Eur J Cancer. 2018;94:6–15. doi:10.1016/j.ejca.2018.01.08329502036
   PubMed Web of Science ®Google Scholar
• Brito JP, Hay ID. Thyroid cancer: overdiagnosis of papillary carcinoma - who benefits? Nat Rev Endocrinol. 2017;13:131–132. doi:10.1038/nrendo.2016.22428059158
   PubMed Web of Science ®Google Scholar
• Rahman ST, McLeod DSA, Pandeya N, et al. Understanding pathways to the diagnosis of thyroid cancer: are there ways we can reduce over-diagnosis? Thyroid. 2019;29:341–348. doi:10.1089/thy.2018.057030700206
   PubMed Web of Science ®Google Scholar
• Conzo G, Calo PG, Gambardella C, et al. Controversies in the surgical management of thyroid follicular neoplasms. Retrospective analysis of 721 patients. Int J Surg. 2014;12:S29–S34. doi:10.1016/j.ijsu.2014.05.013
   PubMed Web of Science ®Google Scholar
• Conzo G, Polistena A, Calo PG, et al. Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis. Int J Surg. 2014;12:S178–S182. doi:10.1016/j.ijsu.2014.05.01524866070
   PubMed Web of Science ®Google Scholar